Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IndividualfiledCriticalIndividual
Priority to CA 2237879priorityCriticalpatent/CA2237879A1/fr
Publication of CA2237879A1publicationCriticalpatent/CA2237879A1/fr
C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Health & Medical Sciences
(AREA)
General Health & Medical Sciences
(AREA)
Steroid Compounds
(AREA)
CA 22378791998-05-191998-05-19Derives de nitrile de 19-nor-steroides a utiliser en radiotherapie et (ou) en imagerie relatives au cancer
AbandonedCA2237879A1
(fr)
Synthesis of 11. beta.-[18F] Fluoro-5. alpha.-dihydrotestosterone and 11. beta.-[18F] Fluoro-19-nor-5. alpha.-dihydrotestosterone: Preparation via halofluorination-reduction, receptor binding, and tissue distribution
Synthesis and biological evaluation of two new radiolabelled estrogens:[125I](E)-3-methoxy-17α-iodovinylestra-1, 3, 5 (10), 6-tetraen-17β-ol and [125I](Z)-3-methoxy-17α-iodovinylestra-1, 3, 5 (10), 6-tetraen-17β-ol
Synthesis and biological evaluation of two new radiolabelled estrogens:[125I](E)-3-methoxy-17a-iodovinylestra-1, 3, 5 (10), 6-tetraen-17b-ol and [125I](Z)-3-methoxy-17a-iodovinylestra-1, 3, 5 (10), 6-tetraen-17b-ol
The metabolism of 16-fluoroestradiols in vivo: Chemical strategies for restricting the oxidative biotransformations of an estrogen-receptor imaging agent
The synthesis and testing of E-17α-(2-iodovinyl)-5α-dihydrotestosterone and Z-17α-(2-iodovinyl)-5α-dihydrotestosterone as γ-emitting ligands for the androgen receptor